Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06356948 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Rate of Tranexamic Acid Administration on Blood Pressure (RateTXA) Study.

Study acronym: RateTXA
StatusCompleted
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed Show 5 more changesShow less
    • Primary completion date changed from estimate of Jul 30, 2027 to Apr 30, 2025
    • Eligibility criteria expanded, about 10 words
    • Secondary endpoints: details revised at 1 of 5 entries
    • Site details revised
    • Publications: details revised at 13 of 13 entries
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Tranexamic acid is a well-established treatment for post-partum hemorrhage. This study aims to examine the effect of tranexamic acid administration rates on blood pressure changes over 1 minute compared to 10 minutes in healthy pregnant patients scheduled for cesarean delivery.
Trial Details
NCT Number NCT06356948
Lead Sponsor University of British Columbia
Conditions
(from sponsor)		 Healthy Participants
Related terms Hypotension, Postpartum Hemorrhage
Enrollment 110 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov